Breast Cancer Care Timeliness Framework: A Quality Framework for Cancer Control
- PMID: 35286134
- PMCID: PMC8932493
- DOI: 10.1200/GO.21.00250
Breast Cancer Care Timeliness Framework: A Quality Framework for Cancer Control
Abstract
Purpose: The aim of this study is to determine the pathway that women follow for Breast Cancer Care (BCC) and the time intervals from symptom discovery to treatment initiation and to develop a quality matrix framework.
Methods: A retrospective cohort study was conducted at six tertiary centers in Malaysia. All women with newly diagnosed breast cancer were interviewed, and a medical records review was conducted using a structured questionnaire. The BCC timeliness framework showed that the total time between a woman discovering their first breast changes and the date of initial treatment was divided into three distinct intervals: presentation interval, diagnostic interval, and treatment interval. Four diagnosis subintervals, referral, biopsy, report, and diagnosis resolution intervals, were also looked into.
Results: The BCC timeliness framework was used to capture important time points. The median total time, presentation interval, diagnostic interval, and treatment interval were 4.9 months (range, 1 month to 10 years), 2.4 months (range, 7 days to 10 years), 26 days (range, 4 days to 9.3 months), and 21 days (range, 1 day to 7.2 months), respectively. Meanwhile, the median time for the diagnosis subinterval of referral, biopsy, report, and diagnosis resolution was 8 days (range, 0 day to 8 months), 0 day (range, 0 day to 20 days), 7 days (range, 3 days to 3.5 months), and 4 days (range, 1 day to 1.8 months), respectively.
Conclusion: The BCC timeliness framework is based on the current sequenced trajectory of the BCC journey. Clarity in the measurement of timeliness provides a standardized language for monitoring and outcome research. It can serve as a quality indicator for community and hospital-based breast cancer programs.
Conflict of interest statement
Figures
References
-
- Globocan : The Global Cancer Observatory; Breast Cancer. Lyon, France, International Agency for Research on Cancer, 2020
-
- National Cancer Registry : Malaysia National Cancer Registry Report 2012-2016 (ed 5). Azizah A, Hashimah B, Nirmal K, et al. (eds): Putrajaya, Malaysia, Ministry of Health Malaysia, 2019, pp 2-116
-
- Yip CH, Pathy NB, Teo SH: A review of breast cancer research in Malaysia. Med J Malaysia 69:8-22, 2014. (suppl A) - PubMed
-
- National Cancer Registry : Malaysian Study on Cancer Survival (MySCan), Volume 4. National Cancer Institute, Ministry of Health Malaysia, Putrajaya, Malaysia, 2018, pp 1-72
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
